KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 18 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,000 | -66.7% | 5,103 | 0.0% | 0.00% | – |
| Q4 2014 | $9,000 | 0.0% | 5,103 | -12.5% | 0.00% | – |
| Q3 2014 | $9,000 | -25.0% | 5,834 | +9.3% | 0.00% | – |
| Q2 2014 | $12,000 | -87.8% | 5,338 | -85.2% | 0.00% | – |
| Q1 2014 | $98,000 | -29.0% | 36,180 | +16.3% | 0.00% | – |
| Q4 2013 | $138,000 | +29.0% | 31,110 | +31.0% | 0.00% | – |
| Q3 2013 | $107,000 | -13.7% | 23,753 | +8.6% | 0.00% | – |
| Q2 2013 | $124,000 | – | 21,872 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opus Point Partners Management, LLC | 746,467 | $358,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 57,604 | $28,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,327,600 | $2,077,000 | 0.00% |
| Renaissance Technologies | 564,673 | $271,000 | 0.00% |
| VALLEY WEALTH MANAGERS, INC. | 15,861 | $8,000 | 0.00% |
| CITIGROUP INC | 2,745 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 14,456 | $7,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 53,635 | $25,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 86,700 | $42,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,055 | $1,000 | 0.00% |